Skip to main navigation Skip to search Skip to main content

Development of Tumor Targeted Nanoparticles to Combat EGFR TKI Resistance

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/19 → 12/31/21

Funding

  • Health Research Inc: $72,500.00